Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Monteil V, Kwon H, Prado P, Hagelkruys A, et al. Cell 2020;181:905-913.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Monteil V, Kwon H, Prado P, Hagelkruys A, et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Cell 2020;181:905-913.
PMID: 32333836